Faron hosts virtual R&D Day today
Faron Pharmaceuticals Oy (“Faron” or the “Company”) Faron hosts virtual R&D Day todayCompany announcement, 16 June 2020 at 9.01 AM (EET) TURKU – FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, will today host a virtual R&D Day via webcast to present its R&D strategy and provide insight into Faron’s two clinical stage programmes, Clevegen and Traumakine. The event will take place today at 3.00 p.m. EEST, 1.00 p.m. BST, 8.00 a.m. EDT. Further to the announcement earlier today, no new price sensitive information will